TW200734638A - Method for the diagnosis of thromboembolic and coronary heart diseases - Google Patents

Method for the diagnosis of thromboembolic and coronary heart diseases

Info

Publication number
TW200734638A
TW200734638A TW095136992A TW95136992A TW200734638A TW 200734638 A TW200734638 A TW 200734638A TW 095136992 A TW095136992 A TW 095136992A TW 95136992 A TW95136992 A TW 95136992A TW 200734638 A TW200734638 A TW 200734638A
Authority
TW
Taiwan
Prior art keywords
thromboembolic
coronary heart
heart diseases
diagnosis
egln2 protein
Prior art date
Application number
TW095136992A
Other languages
English (en)
Inventor
Detlef Kozian
Matthias Herrmann
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of TW200734638A publication Critical patent/TW200734638A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
TW095136992A 2005-10-12 2006-10-05 Method for the diagnosis of thromboembolic and coronary heart diseases TW200734638A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005048899A DE102005048899A1 (de) 2005-10-12 2005-10-12 Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen

Publications (1)

Publication Number Publication Date
TW200734638A true TW200734638A (en) 2007-09-16

Family

ID=37684083

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095136992A TW200734638A (en) 2005-10-12 2006-10-05 Method for the diagnosis of thromboembolic and coronary heart diseases

Country Status (14)

Country Link
US (1) US20090197774A1 (zh)
EP (1) EP1937839B1 (zh)
JP (1) JP2009511026A (zh)
KR (1) KR20080052662A (zh)
CN (1) CN101287846A (zh)
AR (1) AR056125A1 (zh)
AT (1) ATE525481T1 (zh)
AU (1) AU2006301578B9 (zh)
BR (1) BRPI0617341A2 (zh)
CA (1) CA2625698A1 (zh)
DE (1) DE102005048899A1 (zh)
IL (1) IL190585A (zh)
TW (1) TW200734638A (zh)
WO (1) WO2007042165A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005048898A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
EP2152907A1 (en) 2007-05-01 2010-02-17 The Regents of the University of California Methods for diagnosing ischemia
EP2593566B1 (en) 2010-07-14 2018-01-24 The Regents of The University of California Biomarkers for diagnosis of transient ischemic attacks
CN103080339B (zh) 2010-07-15 2016-08-31 加利福尼亚大学董事会 用于诊断卒中及其致因的生物标志物
WO2012121978A2 (en) 2011-03-04 2012-09-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
EP2786154B1 (en) 2011-12-01 2017-11-01 Roche Diagnostics GmbH Nt-proanp and nt-probnp for the diagnosis of stroke
WO2013103781A1 (en) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarkers for diagnosing ischemia
KR101939778B1 (ko) 2012-07-27 2019-01-18 삼성전자주식회사 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003299818A1 (en) * 2002-12-20 2004-07-22 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
WO2004058990A2 (en) * 2002-12-20 2004-07-15 Applera Corporation Genetic polymorphisms associated with stenosis, methods of detection and uses thereof

Also Published As

Publication number Publication date
IL190585A0 (en) 2008-11-03
JP2009511026A (ja) 2009-03-19
ATE525481T1 (de) 2011-10-15
IL190585A (en) 2011-12-29
DE102005048899A1 (de) 2007-04-19
AU2006301578B2 (en) 2011-12-01
WO2007042165A1 (de) 2007-04-19
AU2006301578B9 (en) 2011-12-22
EP1937839A1 (de) 2008-07-02
AU2006301578A1 (en) 2007-04-19
EP1937839B1 (de) 2011-09-21
CN101287846A (zh) 2008-10-15
US20090197774A1 (en) 2009-08-06
BRPI0617341A2 (pt) 2011-07-26
AR056125A1 (es) 2007-09-19
CA2625698A1 (en) 2007-04-19
KR20080052662A (ko) 2008-06-11

Similar Documents

Publication Publication Date Title
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
WO2005014035A3 (en) Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
WO2004092405A3 (en) Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2004006838A3 (en) Novel kinases
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
WO2008093165A3 (en) The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
TW200724679A (en) Treatment of disease using an improved regulated expression system
WO2005077397A3 (en) Methods and compositions for treating vascular diseases
DE50108974D1 (de) Mutanten der den Faktor VII aktivierenden Protease und Nachweisverfahren mit spezifischen Antikörpern
WO2003012099A1 (en) Chondroitin synthase
UA93658C2 (en) Cell surface glycoprotein
DE602005019421D1 (de) Grosstechnisch geeigneter mikroorganismus
WO2005110460A3 (en) Diagnosis and treatment methods related to aging, especially in muscle (14.1)
WO2003025010A3 (en) Human delta-n p73 molecules and uses thereof
WO2005072050A9 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
TW200741011A (en) Method for the diagnosis and treatment of cardiovascular diseases
WO2007049065A3 (en) Vwfa, collagen and kunitz domain containing protein
DE60336596D1 (de) Ortspezifische verabreichung von aktiven substanzen im darm
WO2005116061A3 (de) Sequenzen für die synthese antibakteriell wirkender polyketide
WO2004076613A3 (de) Humane nukleinsäuresequenzen aus harnblasenkarzinomen
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
WO2008014296A3 (en) Composition and method for treatment of tumors